KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Non Operating Income: 2011-2024

Historic Non Operating Income for TherapeuticsMD (TXMD) over the last 14 years, with Dec 2024 value amounting to $2.4 million.

  • TherapeuticsMD's Non Operating Income rose 60.85% to $912,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 34.81%. This contributed to the annual value of $2.4 million for FY2024, which is 209.48% up from last year.
  • Latest data reveals that TherapeuticsMD reported Non Operating Income of $2.4 million as of FY2024, which was up 209.48% from $781,000 recorded in FY2023.
  • TherapeuticsMD's Non Operating Income's 5-year high stood at $2.4 million during FY2024, with a 5-year trough of -$28.0 million in FY2020.
  • Over the past 3 years, TherapeuticsMD's median Non Operating Income value was $781,000 (recorded in 2023), while the average stood at $1.0 million.
  • Per our database at Business Quant, TherapeuticsMD's Non Operating Income slumped by 143.01% in 2022 and then soared by 767.52% in 2023.
  • Yearly analysis of 5 years shows TherapeuticsMD's Non Operating Income stood at -$28.0 million in 2020, then spiked by 100.97% to $272,000 in 2021, then plummeted by 143.01% to -$117,000 in 2022, then soared by 767.52% to $781,000 in 2023, then skyrocketed by 209.48% to $2.4 million in 2024.